日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Synechococcus sp. (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB (miaB) CSB-YP689659FPZ
CSB-EP689659FPZ
CSB-BP689659FPZ
CSB-MP689659FPZ
CSB-EP689659FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Phosphate import ATP-binding protein PstB (pstB) CSB-YP689660FPZ
CSB-EP689660FPZ
CSB-BP689660FPZ
CSB-MP689660FPZ
CSB-EP689660FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Chaperone protein DnaK 2 (dnaK2), partial CSB-YP689661FPZ
CSB-EP689661FPZ
CSB-BP689661FPZ
CSB-MP689661FPZ
CSB-EP689661FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP689662FPZ
CSB-EP689662FPZ
CSB-BP689662FPZ
CSB-MP689662FPZ
CSB-EP689662FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 50S ribosomal protein L19 (rplS) CSB-YP689663FPZ
CSB-EP689663FPZ
CSB-BP689663FPZ
CSB-MP689663FPZ
CSB-EP689663FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. N-acetylmuramic acid 6-phosphate etherase (murQ) CSB-YP689664FPZ
CSB-EP689664FPZ
CSB-BP689664FPZ
CSB-MP689664FPZ
CSB-EP689664FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP689665FPZ
CSB-EP689665FPZ
CSB-BP689665FPZ
CSB-MP689665FPZ
CSB-EP689665FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Sec-independent protein translocase protein TatA (tatA), partial CSB-YP689666FPZ
CSB-EP689666FPZ
CSB-BP689666FPZ
CSB-MP689666FPZ
CSB-EP689666FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP689667FPZ
CSB-EP689667FPZ
CSB-BP689667FPZ
CSB-MP689667FPZ
CSB-EP689667FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. tRNA (guanine-N (7)-)-methyltransferase (trmB) CSB-YP689668FPZ
CSB-EP689668FPZ
CSB-BP689668FPZ
CSB-MP689668FPZ
CSB-EP689668FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 3-dehydroquinate synthase (aroB) CSB-YP689669FPZ
CSB-EP689669FPZ
CSB-BP689669FPZ
CSB-MP689669FPZ
CSB-EP689669FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Heat-inducible transcription repressor HrcA (hrcA) CSB-YP689670FPZ
CSB-EP689670FPZ
CSB-BP689670FPZ
CSB-MP689670FPZ
CSB-EP689670FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 50S ribosomal protein L10 (rplJ) CSB-YP689671FPZ
CSB-EP689671FPZ
CSB-BP689671FPZ
CSB-MP689671FPZ
CSB-EP689671FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem II reaction center protein T (psbT), partial CSB-YP689672FPZ
CSB-EP689672FPZ
CSB-BP689672FPZ
CSB-MP689672FPZ
CSB-EP689672FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP689673FPZ
CSB-EP689673FPZ
CSB-BP689673FPZ
CSB-MP689673FPZ
CSB-EP689673FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem Q (B) protein 2 (psbA2), partial CSB-YP689674FPZ1
CSB-EP689674FPZ1
CSB-BP689674FPZ1
CSB-MP689674FPZ1
CSB-EP689674FPZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Probable transcriptional regulatory protein syc0529_d (syc0529_d) CSB-YP689675FPZ
CSB-EP689675FPZ
CSB-BP689675FPZ
CSB-MP689675FPZ
CSB-EP689675FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Ribonuclease PH (rph) CSB-YP689676FPZ
CSB-EP689676FPZ
CSB-BP689676FPZ
CSB-MP689676FPZ
CSB-EP689676FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. UPF0754 membrane protein syc0451_d (syc0451_d), partial CSB-YP689677FPZ1
CSB-EP689677FPZ1
CSB-BP689677FPZ1
CSB-MP689677FPZ1
CSB-EP689677FPZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Guanylate kinase (gmk) CSB-YP689678FPZ
CSB-EP689678FPZ
CSB-BP689678FPZ
CSB-MP689678FPZ
CSB-EP689678FPZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×